Structural heart disease refers to abnormalities in the heart’s valves, chambers, walls, or nearby major vessels that can disrupt blood flow and heart function. Treating it often requires specialized imaging, procedural skills, and coordinated care that are not available at every hospital. The need is growing: the Society of Thoracic Surgeons and American College of Cardiology’s TVT Registry recorded more than 100,000 transcatheter aortic valve replacement procedures in the United States in 2023, while population aging is increasing the number of people living with valve disease. The expertise gap matters because accurate diagnosis, timely referral, and experienced multidisciplinary teams can influence which treatment is appropriate and how safely it is delivered.
Structural heart disease requires specialized expertise
Structural heart disease is a broad category rather than one diagnosis. It includes conditions such as aortic stenosis, mitral valve disease, tricuspid valve disease, congenital heart defects, and selected leaks or openings between heart chambers. The American Heart Association describes heart valve disease as damage or disease affecting one or more of the heart’s valves, which may become narrowed or fail to close properly.
The expertise required extends beyond performing a procedure. Teams must interpret detailed imaging, assess symptoms and overall health, compare surgical and catheter-based options, manage complications, and arrange follow-up. These capabilities are concentrated in specialized programs, so patients may need referral to a regional center rather than treatment at the nearest hospital.
Why the expertise gap matters
Structural interventions are highly dependent on patient selection and procedural planning. For example, aortic valve replacement may be performed through open surgery or by transcatheter aortic valve replacement (TAVR), a catheter-based treatment in which a replacement valve is delivered through a blood vessel or another access route. The best choice depends on factors including anatomy, age, frailty, other medical conditions, life expectancy, and patient preferences.
The 2020 American College of Cardiology and American Heart Association guideline for valvular heart disease recommends that patients with severe valve disease being considered for intervention be evaluated by a multidisciplinary valve team at a Primary or Comprehensive Valve Center. This reflects the reality that no single specialty can address every relevant question. Cardiologists, cardiac surgeons, imaging specialists, anesthesiologists, nurses, and other clinicians may all contribute.
A growing and geographically concentrated field
The rise of catheter-based therapies has expanded treatment possibilities, but it has also increased the need for specialized training and infrastructure. The TVT Registry, maintained by the Society of Thoracic Surgeons and the American College of Cardiology, reported more than 100,000 U.S. TAVR procedures in 2023. That scale represents substantial access to treatment, but it does not mean that every hospital has the teams, imaging systems, procedural volume, or round-the-clock support needed to provide it.
Access can depend on where a patient lives, referral patterns, insurance coverage, transportation, and the availability of specialists. The Centers for Disease Control and Prevention notes that heart valve disease becomes more common with age. As the population ages, the number of people needing evaluation is likely to grow, making timely identification and referral increasingly important.
Structural heart programs depend on multidisciplinary care
A structural heart program is a coordinated clinical service for evaluating and treating diseases involving the heart’s valves and structures. The American College of Cardiology’s valve-center framework emphasizes specialized expertise, a team-based approach, appropriate diagnostic resources, and processes for evaluating outcomes. In practice, the program connects diagnosis, treatment planning, intervention, and follow-up rather than treating a procedure as an isolated event.
The heart team
The heart team is the group of clinicians who jointly assess a patient and recommend a treatment plan. Depending on the condition, it may include an interventional cardiologist, cardiac surgeon, noninvasive cardiologist, cardiac imaging specialist, cardiac anesthesiologist, and advanced practice clinicians. The team considers both technical feasibility and the patient’s goals, overall health, and likely recovery.
This shared assessment is especially important when reasonable options differ. A catheter-based treatment may reduce the need for open surgery for some patients, but it is not automatically preferable for everyone. The team must consider whether the anatomy is suitable, whether another heart condition should be treated at the same time, and what future interventions may be needed.
Imaging and procedural planning
Structural heart care relies on imaging that can define anatomy and guide treatment. Echocardiography uses ultrasound to assess valve structure and function. Computed tomography can help characterize anatomy and plan access for procedures such as TAVR. During some interventions, transesophageal echocardiography and fluoroscopy provide real-time guidance.
The American Society of Echocardiography publishes guidance on the use of echocardiography in valve assessment and intervention. Imaging specialists help clinicians distinguish disease severity, identify complications, and determine whether a proposed device or procedure is suitable. A hospital without appropriate imaging expertise may have difficulty making a definitive assessment or supporting complex treatment safely.
Infrastructure, volume, and quality oversight
A capable program needs more than a catheterization laboratory. It may require cardiac surgery backup, specialized anesthesia, intensive care, blood-bank support, trained nursing teams, device coordination, and systems for urgent complications. Programs also need reliable processes for documenting outcomes and reviewing complications.
The TVT Registry supports national tracking of transcatheter valve procedures and quality improvement. Registry participation can help programs compare practice and outcomes, but a registry alone does not guarantee quality. Patients and referring clinicians should consider the center’s experience with the specific condition and procedure, its team structure, and how it measures and communicates results.
Common conditions show why expertise must be tailored
Structural heart disease includes several distinct conditions, and expertise in one procedure does not automatically establish expertise in all others. Each diagnosis has its own imaging requirements, treatment options, and risks. The following examples illustrate why a specialized evaluation can matter.
Aortic stenosis and TAVR
Aortic stenosis is narrowing of the aortic valve that can obstruct blood leaving the heart. Severe disease may cause breathlessness, chest discomfort, fainting, or heart failure, although symptoms can be subtle. The American College of Cardiology and American Heart Association guideline recommends intervention for selected patients with severe disease, with the choice between surgery and TAVR based on clinical and anatomical factors.
TAVR has transformed treatment for many people with aortic stenosis, including patients at different surgical-risk levels. Yet planning requires careful measurement of the valve and surrounding structures, selection of a suitable access route, and preparation for potential complications. A patient should not assume that a procedure is appropriate solely because it is available at a nearby facility.
Mitral and tricuspid valve disease
Mitral valve disease can involve narrowing or leakage, while tricuspid disease often involves leakage that may contribute to swelling, liver congestion, or worsening heart failure. These conditions can be difficult to assess because symptoms overlap with other illnesses and because the mechanism of valve dysfunction affects treatment choices.
Some patients may be candidates for catheter-based repair or replacement, while others may need surgery, medication, or ongoing observation. Detailed echocardiography, sometimes combined with other imaging, helps determine the cause and severity of the problem. Decisions may also account for heart rhythm, lung pressure, kidney function, and other valve conditions.
Congenital defects and other structural conditions
Congenital heart defects are structural abnormalities present from birth. Some are detected in childhood, while others are discovered in adulthood or require continued care after earlier treatment. Examples include openings between chambers and abnormalities involving the valves or major vessels.
Adult congenital heart disease may require clinicians familiar with both congenital anatomy and adult cardiovascular conditions. The 2018 American Heart Association and American College of Cardiology guideline for adults with congenital heart disease emphasizes specialized evaluation and follow-up for patients with more complex disease. This is another reason general cardiology access, while essential, may not be enough for every structural problem.
Referral pathways can close the expertise gap
When local services cannot provide the required evaluation or intervention, a clear referral pathway can connect patients to a center with appropriate expertise. Referral does not necessarily mean a patient must permanently leave their community: local clinicians can often continue routine care in coordination with the specialized center.
Recognizing when specialist evaluation is needed
A new or worsening heart murmur, unexplained breathlessness, chest discomfort, fainting, reduced exercise tolerance, or signs of heart failure may prompt further assessment. These symptoms are not specific to valve disease, so clinicians use examination and diagnostic testing rather than symptoms alone to establish a diagnosis.
Patients with diagnosed severe valve disease, uncertain imaging results, multiple valve problems, or consideration of an intervention may benefit from review by a multidisciplinary valve team. The American College of Cardiology and American Heart Association guideline supports team-based assessment for patients being considered for valve intervention.
Questions patients and referring clinicians can ask
- Which valve or heart structure is affected, and how severe is the disease?
- What tests support the diagnosis, and should the imaging be reviewed by a specialist?
- What are the reasonable options, including monitoring, medication, surgery, or a catheter-based procedure?
- How often does the proposed center perform this specific intervention, and how does its team review outcomes?
- Who will coordinate follow-up with the patient’s local clinician after treatment?
A practical example of coordinated care
Consider an older adult with worsening breathlessness and an echocardiogram suggesting severe aortic stenosis. A local clinician may arrange specialist imaging review and refer the patient to a valve center. The heart team can then assess symptoms, valve anatomy, frailty, other medical conditions, and the patient’s preferences before recommending monitoring, TAVR, or surgery. After treatment, the local clinician and specialist center can share responsibility for recovery and ongoing valve surveillance.
This example illustrates the value of a connected pathway: local clinicians identify a possible problem, specialists confirm and characterize it, a team recommends treatment, and follow-up continues across settings. It is not a substitute for individual medical advice; decisions should be made with qualified clinicians who know the patient’s circumstances.
Conclusion: expertise must grow with the need
Structural heart disease encompasses valve disorders, congenital abnormalities, and other conditions that may require highly specialized diagnosis and treatment. The growth of TAVR and other catheter-based therapies has widened treatment options, but safe care still depends on accurate imaging, a multidisciplinary heart team, appropriate infrastructure, and reliable follow-up. With more than 100,000 TAVR procedures recorded in the United States in 2023 and valve disease becoming more common with age, the need for skilled programs and effective referral networks is substantial.
Patients, caregivers, and referring clinicians can help close the expertise gap by seeking timely assessment, asking whether a valve-team review is appropriate, and coordinating care between community clinicians and specialized centers. Further reading from the American College of Cardiology, American Heart Association, Centers for Disease Control and Prevention, and Society of Thoracic Surgeons can help readers understand valve disease, treatment choices, and quality resources.
Sources: Otto CM, Nishimura RA, Bonow RO, et al., 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease, Journal of the American College of Cardiology, https://www.jacc.org/doi/10.1016/j.jacc.2020.11.018; Society of Thoracic Surgeons and American College of Cardiology, TVT Registry, https://www.sts.org/registries-research-center/sts-acc-tvtr; Centers for Disease Control and Prevention, About Heart Valve Disease, https://www.cdc.gov/heart-disease/about/heart-valve-disease.html; American Heart Association, What Is Heart Valve Disease?, https://www.heart.org/en/health-topics/heart-valve-problems-and-disease/about-heart-valve-problems-and-disease; American Society of Echocardiography, Guidelines and Standards, https://www.asecho.org/guidelines/; Stout KK, Daniels CJ, Aboulhosn JA, et al., 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease, Journal of the American College of Cardiology, https://www.jacc.org/doi/10.1016/j.jacc.2018.08.1029.